{"id":3478,"date":"2020-04-03T00:00:00","date_gmt":"2020-04-03T00:00:00","guid":{"rendered":"http:\/\/pl-asapbio.local\/state-of-preprinting-2020-04\/"},"modified":"2025-03-28T21:37:19","modified_gmt":"2025-03-28T21:37:19","slug":"state-of-preprinting-2020-04","status":"publish","type":"post","link":"https:\/\/asapbio.org\/state-of-preprinting-2020-04\/","title":{"rendered":"The state of preprinting in biomedical sciences"},"content":{"rendered":"

The use of preprints has increased rapidly over the last few years, especially in biomedical and life sciences. We\u2019ve been tracking changes in the preprint landscape over time and maintain a page<\/a> dedicated to this topic. Here are some of the most notable trends over the last year.<\/p>\n

<\/div>\n

Adoption and sources<\/h4>\n
<\/div>\n<\/p>\n
\n
\"Plot<\/figure>\n<\/div>\n

The rate of life sciences preprints posted per month continues to increase, putting our current estimate of the fraction of the biomedical literature represented as preprints at just over 3% (data<\/a>). In the last year, the source of these preprints has undergone a notable shift driven by the emergence of In Review<\/a>, Springer Nature\u2019s preprint service on the Research Square platform, as well as continued growth of bioRxiv<\/a>. MedRxiv<\/a> also launched in the last year, and submissions are growing steadily, while PeerJ Preprints<\/a> closed<\/a>.<\/p>\n

<\/div>\n
\n
\"Plot<\/figure>\n<\/div>\n

Note that this chart does not yet incorporate preprints from OSF.<\/p>\n

<\/div>\n

COVID-19 response<\/h4>\n

In the wake of the COVID-19 pandemic, over 100 publishers, funders, and other organizations announced support for preprints<\/a>, and many servers offer collections that highlight relevant work:<\/p>\n